Next, the Kaplan–Meier plotter database was used to evaluate the prognosis of ITGA3 in patients with breast cancer, ovarian cancer, lung cancer and gastric cancer, as well as the prognosis under different pathological subtypes. This evidence concerns the gene ITGA3 and breast carcinoma.